Rationale: Chronic obstructive pulmonary disease (COPD) is characterized by airflow
limitation caused by emphysema and/or airway narrowing. Computed tomography has been …

Rationale: Although the rate of annual decline in FEV 1 is one of the most important
outcome measures in chronic obstructive pulmonary disease (COPD), little is known about …

Pulmonary macrophages are one of the sources of various antioxidant and detoxification
enzymes for which NF-E2–related factor 2 (Nrf2) is a key transcriptional factor. Although Nrf2 …

Background: Airflow limitation in chronic obstructive pulmonary disease (COPD) is caused by
a mixture of small airway disease and emphysema, the relative contributions of which may …

Chronic airway inflammation, one of the pathophysiologic features of bronchial asthma, is
suspected to be responsible for irreversible pathological changes of airways, called airway …

Rationale: Inhaled granulocyte/macrophage–colony stimulating factor (GM-CSF) is a promising
therapy for pulmonary alveolar proteinosis (PAP) but has not been adequately studied. …

Glucocorticoids are highly effective in controlling chronic inflammatory diseases, such as
asthma and rheumatoid arthritis, but the exact molecular mechanism of their anti‐inflammatory …

Curcumin, a yellow pigment obtained from turmeric (Curcumina longa), is a dietary polyphenol
that has been reported to possess anti-inflammatory and antioxidant properties. The …

The inflammatory chemokines interleukin-8, macrophage inflammatory protein-1α, and
monocyte chemoattractant protein-1, are reportedly involved in the pathogenesis of chronic …

Background Previous SARS-CoV-2 infection and vaccination, coupled with the rapid evolution
of SARS-CoV-2 variants, have modified COVID-19 clinical manifestations. We aimed to …